“Negligible impact of highly patient-specific decision support for potassium-increasing drug-drug interactions – a cluster-randomised controlled trial”, Swiss Med Wkly, vol. 149, no. 1516, p. w20035, Apr. 2019, doi: 10.4414/smw.2019.20035.